| 查看: 2106 | 回复: 8 | |||||
[交流]
关于Biomaterials投稿
|
|
第一次投Biomaterials，有好多问题不是太懂，谁投过给些建议。 1.实验数据是不是放在文章的最后面 2.A template for the covering letter is found on the Biomaterials website.我没找到，想问一下你们在哪找到的 |
回复此楼» 猜你喜欢
交叉科学部支持青年基金，对三无青椒是个机会吗？
已经有4人回复
-
招博士
已经有6人回复
-
限项规定
已经有8人回复
-
国家基金申请书模板内插入图片不可调整大小?
已经有5人回复
-
国家级人才课题组招收2026年入学博士
已经有5人回复
-
Fe3O4@SiO2合成
已经有6人回复
-
青年基金C终止
已经有4人回复
-
青椒八年已不青，大家都被折磨成啥样了？
已经有7人回复
-
为什么nbs上溴 没有产物点出现呢
已经有10人回复
-
救命帖
已经有11人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 关于一篇文献的题目
已经有5人回复
- 2012 SCI impact factor 生物材料类 评点
已经有9人回复
- 论文投稿刊物选择
已经有1人回复
» 抢金币啦！回帖就可以得到:
-
邀您投稿 Polymers 特刊
+1/478
-
南方科技大学周友运课题组诚聘博士后、科研助理
+1/186
-
招聘启事 江南大学乳品加工与营养健康团队博士后招聘
+2/110
-
限广州，征女友
+2/96
-
南京林业大学特聘教授招聘博后和博士研究生
+1/75
-
关于本子打包
+1/67
-
征婚
+1/60
-
招收博士生（大连理工大学，2026.09入学）
+1/49
-
诚征女友，非诚勿扰
+3/44
-
中国科学院上海光学精密机械研究所 特种强激光薄膜课题组
+1/26
-
武汉大学博士生/直博生招聘（微纳光驱动与片上光子学）
+5/20
-
青岛大学化学院泰山学者冯佳课题组申请考核制博士招生
+1/13
-
博士后, 博士招生 美国大纽约地区 NJIT
+1/11
-
中山大学柔性电子学院黄维院士团队诚招柔性可穿戴电子方向博士生（2026年9月入学）
+1/7
-
中国石油大学（北京）2026年博士招生2名：化学、材料、石油工程：油田化学
+2/6
-
关于冻干品状态不好的求助，等候各位高人的解答
+1/6
-
深圳大学院士团队2026“申请-考核制”博士研究生招生
+1/2
-
复旦大学2026年博士研究生，“药学 + 合成生物学”
+1/1
-
浙江大学 “分子智造”课题组 诚聘 博士后及科研助理
+1/1
-
山东大学集成电路学院太赫兹团队博士招生(2026年2月底前)
+1/1
nono2009
超级版主 (文学泰斗)
-
专家经验: +21105 - SEPI: 10
- 应助: 28684 (院士)
- 贵宾: 513.911
- 金币: 2555220
- 帖子: 1602255
- 在线: 65200.9小时
- 虫号: 827383
★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
小木虫: 金币+0.5, 给个红包，谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
|
楼主是看的这里吗：http://www.elsevier.com/journals ... 2/guide-for-authors 这么没有查到你说的A template for the covering letter is found on the Biomaterials website |
2楼2012-11-17 19:30:02
3楼2012-11-17 22:01:53
★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
小木虫: 金币+0.5, 给个红包，谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
|
亲，你可以在EES的主页上的右边栏上点Author declaration，然后就会直接下载一个word版本的author declaration，而 A template for the covering letter will be found at the end of this document：顺便给你复制了一个，因为好还不会用附件啊 We the undersigned declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere. We would like to draw the attention of the Editor to the following publications of one or more of us that refer to aspects of the manuscript presently being submitted. Where relevant copies of such publications are attached. [CAN BE DELETED IF NOT RELEVANT] We wish to draw the attention of the Editor to the following facts which may be considered as potential conflicts of interest and to significant financial contributions to this work. [OR] We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property. We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. [CAN BE DELETED IF NOT RELEVANT] We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from biomaterials@online.be. Signed by all authors as follows: [LIST AUTHORS AND DATED SIGNATURES ALONGSIDE] |
4楼2012-11-17 22:38:10
5楼2012-11-18 09:19:31
6楼2013-04-22 16:56:56
7楼2013-04-23 08:50:25
8楼2013-04-23 13:28:19
9楼2013-04-24 19:43:46